APA (7th ed.) Citation

J, V., E, C., P, L., RS, W., J, A., AG, C., . . . M, L. (2023). A Phase I Trial of Allogeneic γδ T Lymphocytes From Haploidentical Donors in Patients With Refractory or Relapsed Acute Myeloid Leukemia. Clinical lymphoma, myeloma & leukemia, 23(5), e232. https://doi.org/10.1016/j.clml.2023.02.003

Chicago Style (17th ed.) Citation

J, Vydra, Cosimo E, Lesný P, Wanless RS, Anderson J, Clark AG, Scott A, Nicholson EK, and Leek M. "A Phase I Trial of Allogeneic γδ T Lymphocytes From Haploidentical Donors in Patients With Refractory or Relapsed Acute Myeloid Leukemia." Clinical Lymphoma, Myeloma & Leukemia 23, no. 5 (2023): e232. https://doi.org/10.1016/j.clml.2023.02.003.

MLA (9th ed.) Citation

J, Vydra, et al. "A Phase I Trial of Allogeneic γδ T Lymphocytes From Haploidentical Donors in Patients With Refractory or Relapsed Acute Myeloid Leukemia." Clinical Lymphoma, Myeloma & Leukemia, vol. 23, no. 5, 2023, p. e232, https://doi.org/10.1016/j.clml.2023.02.003.